Patients will be able to find out whether they have genes linked to cancer using a world-leading tool developed by the NHS.

Join Tom and Mike as they share an important update on Tom's prostate cancer journey. In this video, they discuss Tom's ...

Prostate cancer is the second-most common cancer in men. A new study from Thomas Jefferson University uncovered a new ...

Jersey Shore’s Nicole “Snooki” Polizzi recently detailed some cancerous cells were found in her cervix, encouraging followers ...

ZERO Prostate Cancer (ZERO), announces the 2026 Veterans’ Action Convening, a national gathering committed to strengthening ...

This article was reviewed by Darragh O’Carroll, MD. Key Takeaways: Many men’s health issues are either entirely preventable ...

In a randomized trial of men with a single suspicious lesion on MRI, targeted perilesional biopsy matched standard targeted and systematic biopsy for detecting clinically significant prostate cancer - ...

Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment.

January 23, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences ...

Alpha Tau Medical targets major 2026 catalysts as Alpha DaRT gains momentum; key pancreatic & GBM readouts ahead. Read the full analysis here of DRTS stock.

New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate ...